title: Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option.
abstract: Two large, recently published observational studies demonstate a clear down-trend in the use of radiotherapy (RT) over the last 15 years, both in the setting of follicular and diffuse large B-cell lymphoma. This change of practice might have a negative impact on clinical outcome. Even within the context of modern systemic therapy, omission of RT translates not only into a shorter progression-free survival (PFS), but also into a worse overall survival (OS). RT should therefore remain standard practice.This short review is aiming to summarize current guidelines and the best evidence available in the management of non-Hodgkin's lymphoma. Potentially practice changing, ongoing trials will be highlighted.
authors: Department of Radiation Oncology, Kantonsspital Graubünden, Loëstrasse 170, 7000, Chur, Switzerland.
authors: Michel
authors: M
authors: Zimmermann
authors: Department of Radiation Oncology, Kantonsspital Graubünden, Loëstrasse 170, 7000, Chur, Switzerland.
authors: Christoph
authors: C
authors: Oehler
authors: Department of Medical Oncology and Haematology, Kantonsspital Graubünden, Chur, Switzerland.
authors: Ulrich
authors: U
authors: Mey
authors: Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany.
authors: Pirus
authors: P
authors: Ghadjar
authors: Department of Radiation Oncology, Kantonsspital Graubünden, Loëstrasse 170, 7000, Chur, Switzerland. daniel.zwahlen@ksgr.ch.
authors: Daniel Rudolf
authors: DR
authors: Zwahlen
mesh_terms: D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000532:radiotherapy*